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Background: Dengue fever is a tropical infectious disease caused by dengue virus (DENV), a single positive-stranded
RNA Flavivirus. There is no published evidence of dengue in Zambia. The objective of the study was to determine the
sero-prevalence and correlates for dengue fever specific IgG antibodies in Western and North-Western provinces in
Zambia.
Methods: A randomized cluster design was used to sample participants for yellow fever risk assessment. In order to
rule out cross reactivity with other flaviviruses including dengue, differential antibody tests were done by ELISA. Data
was processed using Epi Data version 3.1 and transferred to SPSS version 16.0 for analysis. Bivariate and multivariate
analyses were performed to determine the association of dengue fever with various factors. Unadjusted odds ratios
(OR), adjusted odds ratios (AOR) and their 95% confidence intervals (CI) are reported.
Results: A total of 3,624 persons were sampled for dengue virus infection of whom 53.3% were female and 23.9% were
in the 5–14 years age group. Most persons in the survey attained at least primary education (47.6%). No significant
association was observed between sex and dengue virus infection (p = 1.000). Overall, 4.1% of the participants tested
positive for Dengue IgG. In multivariate analysis, the association of age with Dengue infection showed that those below
5 years of age were 63% (AOR = 0.37; 95% CI [0.16, 0.86]) less likely to be infected with Dengue virus compared to those
aged 45 years or older. A significant association was observed between grass thatched roofing and Dengue infection
(AOR = 2.28; 95% CI [1.15, 4.53]) Respondents who used Insecticide Treated Nets (ITN) were 21% (AOR = 1.21; 95%
CI [1.01, 1.44]) more likely to be infected with dengue infection than those who did not use ITNs. Meanwhile, participants
who visited Angola were 73% (AOR = 1.73; 95% CI [1.27, 2.35]) more likely to be infected with Dengue virus than those
who did not visit Angola.
Conclusion: This study provides the first evidence of dengue infection circulation in both North-Western and Western
provinces of Zambia. It is important that surveillance activities for Dengue and diagnostic systems are expanded and
strengthened, nationwide in order to capture information related to dengue virus and other flaviviruses.
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Dengue fever is a tropical infectious disease caused by
Dengue virus (DENV), a single positive-stranded RNA
virus of the family Flaviviridae; genus Flavivirus [1].
Dengue virus infection is classified into dengue with or
without warning signs and severe dengue. Dengue with or
without warning signs is further classified into probable
dengue and laboratory-confirmed dengue. A case of
probable dengue would have lived in/travelled to dengue
endemic areas and has fever and 2 of the following
criteria: nausea/vomiting, rash, aches and pains, tourniquet
test positive, leukopenia and any of the following:
abdominal pain or tenderness, persistent vomiting,
clinical fluid accumulation, mucosal bleed, lethargy/
restlessness, liver enlargement of more 2 cm and increase
in HCT concurrent with rapid decrease in platelet count.
Meanwhile, severe dengue is classified as severe plasma
leakage leading to dengue shock syndrome and fluid
accumulation with respiratory distress; severe bleeding and
severe organ (such as liver, CNS and heart) involvement
[1,2]. Without adequate clinical management, mortality
stands at 1–5% [3] and usually less than 1% with adequate
clinical management [1]. However, severe disease carries a
mortality of 26% [3]. The disease is transmitted between
people by mosquito species Aedes aegypti and Aedes
albopictus [4]. The main vector associated with Dengue
fever is Aedes aegypti [5] which is found worldwide
between latitudes 35°N and 35°S [6]. Robinson GG.
documented presence of Aedes Aegypti (L) in Zambia [7].
The disease is now endemic in more than 100 countries
in Africa, the Americas, the Eastern Mediterranean,
South-east Asia and Western Pacific [8]. It has become
common in Africa and amongst travellers from the tropics
and subtropics. Dengue fever is common amongst
travellers from the tropics and subtropics [9]. Zambia
which lies between latitude 8° and 18°S and longitude
22° and 34°E is considered generally of tropical climate
[10,11]. However, the contemporary worldwide risk of
dengue virus infection is poorly known [9].
The dengue virus in Africa has been traced as far
back as 1926 having caused an epidemic in Durban,
South Africa [12,13]. Though surveillance for dengue
in Africa is poor, it is known that dengue epidemics
have increased dramatically since 1980. Most activity
has been documented in East Africa and major out
breaks in many countries including Seychelles, Kenya,
Mozambique, Djibouti, Somalia and Saudi Arabia between
the 1970’s and 1990’s [14]. Between 2009 and 2012
outbreaks were reported in more countries in Africa
including Cape Verde, Cote d’Ivoire, Gabon, Senegal
in West Africa, Djibouti [15,16] and in Kenya and
Sudan in East Africa [17]. Most recently in 2013, Africa
recorded dengue outbreaks in Angola, Kenya, Seychelles
and Tanzania [18].Zambia had no documented evidence of dengue infection
except for a confirmed case of a European traveller/
expatriate who was in Zambia between 1987 and 1993
[15]. Travel by air, motor vehicles or foot increases the
risk of introducing arthropod-borne virus diseases
from endemic to non-endemic areas [19]. There is increas-
ing travel between the dengue endemic neighbouring
countries and Zambia [20].
Zambia is a land linked country surrounded by countries
endemic with dengue fever including Angola, Democratic
Republic of Congo, Tanzania and Mozambique and yet
there is no documented evidence of dengue fever. Zambia
could be considered a risk area for dengue virus circulation,
considering it neighbours dengue endemic countries,
has tropical climate and carries the dengue vector Aedes
aegypti [15,18].
Recently during the Yellow Fever risk assessment
conducted in two provinces of Zambia (Western and
North-Western provinces), Zambia confirmed presence of
dengue fever IgG antibodies in persons participating in
the survey. IgG antibodies against dengue are detectable
after 10–14 days of onset and once infected; one has life
immunity to the specific serotype they were infected with
[21]. This paper describes the sero-prevalence and
correlates for dengue fever specific IgG antibodies in
Western and North-Western provinces in Zambia.
Methods
Study site
The study was conducted in Western and North-Western
provinces of Zambia. These two provinces were selected by
virtue of being classified as low potential risk for yellow
fever transmission by a World Health Organisation (WHO)
Yellow Fever Technical Working Group in 2010 [22].
Western province borders with Angola and has seven dis-
tricts divided into 1902 Standard Enumeration Aras (SEAs).
T2e population was at 902,974 with a population density of
7.0 [23]. Crop and livestock production as well as fishing
were the main economic activities [24]. North Western
province borders with Angola on the western side and
Democratic Republic of Congo (DRC) on the northern side.
The province had 8 districts that were divided into 1178
SEAs. The 2010 census reveals a population of 727,044
with population density of 5.6 [23]. The main economic
activity was pineapple growing, with fast growing mining
activities in one of the districts, Solwezi [24].
Zambia Demographic Health Survey, 2007 reports
46.9 and 53.2 per cent of the population slept under an
Insecticide Treated Net in the previous night to the survey
in Western and North-Western Provinces respectively [25].
Study population
This assessment was carried out among individuals aged
nine months or older.
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The sample size calculation was based on the assumption
that the sero-prevalence was 7% based on the study
conducted by Robinson [7].
In estimating the sample size for persons aged 5 years
or older, the following parameters were considered: a
prevalence of 7%, desired precision or confidence
interval (d) of +3%, and a design effect (DE) of 2 and
an 80% response rate.
Considering sex, we aimed to recruit 700 male and
700 female participants in each province. Assuming an
average of 4 persons aged 5 years or older in each
household, a total of 12 households in each of the
30 clusters were to be recruited in the survey. The total
number of adult persons that would be recruited from
each province was 1400.
The sero-prevalence of children below 5 years was
about half that for older children, and in estimating the
sample size for persons aged below 5 years, the following
parameters were considered: a prevalence of 3.5%,
desired precision or confidence interval (d) of +3.4%,
and a design effect (DE) of 2 and an 80% response
rate. A total of 406 children in each province would
be recruited for the survey.
Any individual aged 9 months or older and who was a
member of a sampled household and resident in the
study site for at least seven days was eligible to participate
in the survey. Individuals who received YF vaccination
in the last ten years to the survey were also eligible
to participate in the survey.
Any person, who was either less than 9 months of age,
or any person regardless of age, who resided in the
study site for a period of less than seven days prior
to the survey was excluded from the study. Determining
the sero-prevalence in children under the age of nine
months raises the risk of false positive results as children
under this age may still carry maternal antibodies from
immunized or exposed mothers.
The sample was drawn using a two-stage cluster
sampling technique using probability proportional to
size. A list of the standard enumeration areas (SEAs)
in each province constituted the sampling frame. The
line lists of the SEAs were provided by the Zambian
Government’s Central Statistics Office (CSO). The study
was designed to obtain estimates at the provincial level of




A case with evidence of dengue infection exposure
was defined as any individual aged 9 months or older
whose blood sample was confirmed to have dengue
virus exposure through any of the following:Detection of Dengue virus-specific IgG and IgM antibodies
Dengue Fever exposure status was therefore determined
by way of laboratory testing as ‘positive’, for a respond-
ent with laboratory evidence of dengue virus exposure
or as ‘negative’, for a respondent who did not have la-
boratory evidence of dengue virus exposure.
Independent variables
The independent variables included age, sex, occupation,
visitation to Angola and/or DRC, use of mosquito
preventive measures (ITNs and Insecticide Residual
Spray) and type of roofing.
Laboratory procedure
About 3 to 5 millilitres of blood was collected by
venepuncture into a plain (red top) vacutainer tube
and transported on cold chain to the local laboratories for
serum separation and storage.
Serum samples were transported on cold chain and
thereafter subjected to primary testing (YFV specific IgG
and IgM) at the University of Teaching Hospital in
Zambia Virology Unit and Institute Pasteur, Dakar (WHO
regional reference laboratory (RRL)). All presumptive
YFV-specific IgG and IgM samples were subjected to IgG
and IgM antibodies testing against other flaviviruses
known to cause haemorrhagic fever-like disease including
dengue at the RRL. The testing was carried out using IgG
capture enzyme-linked immunosorbent assay (ELISA).
Data management and analysis
Field data were entered in an Epi Data version 3.1 entry
screen that had consistency and range checks embedded
in it. Further editing was conducted by running frequencies
during the analysis stage. Epi data files were exported to
SPSS version 16.0 for data analysis. The data was summa-
rized to describe the occurrence of dengue virus exposed
individuals in absolute numbers and percentage by place
(residence, travel, roof type or work) and person (age, sex,
occupation). Bivariate and multivariate analyses were
conducted to determine independent factors associated
with dengue IgG sero-positivity. Odds ratios were used to
estimate the magnitude of associations. Unadjusted odds
ratios (OR) and adjusted odds ratios (AOR) and their
95% confidence intervals (CI) are reported. Yates correlated
Chi-square and Pearson’s Chi-square were, where appropri-
ate, used to compare proportions at 5% significance level.
Ethical considerations
Ethical clearance was sought from the Tropical Diseases
Research Centre Research Ethics Committee in Ndola,
Zambia, and ethical standards were adhered to throughout
this study. Informed consent was sought from study partic-
ipants. Guardians provided assent for the participation of
the persons under the consenting age. They were asked to
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print an informed consent form. Responsible adults in the
household were identified to give proxy consent on behalf
of minors.
Results
A total of 3,624 persons were sampled for dengue virus
infection of whom 23.9% were in the 5–14 years age
group. Of the total persons sampled 53.3% were female.
Most of the persons in the survey attained at least
primary education (47.6%). Male participants tended to
be more educated than female participants (p < 0.001).
No significant difference was observed between sex and
dengue virus infection (p = 1.000). Overall, 4.1% of the
participants were found to have had previous dengue
infection. These results are shown in Table 1. The special
distribution of previous dengue infection was widely
spread in the study area (Figure 1).Table 1 Sample description for North-Western and
Western provinces for dengue virus infection
Factor Total Male Female
n (%) n (%) n (%)
Age (years) [x2 = 10.41, p = 0.065]
<5 335 (9.4) 155 (9.3) 178 (9.4)
5-14 853 (23.9) 424 (25.4) 429 (22.6)
15-24 738 (20.6) 344 (20.6) 392 (20.6)
25-34 593 (16.6) 245 (14.7) 348 (18.3)
35-44 460 (12.9) 214 (12.8) 245 (12.9)
45+ 596 (16.7) 286 (17.1) 310 (16.3)
Sex
Male 1669 (46.7) - -
Female 1902 (53.3) - -
Education [x2 = 37.47, p < 0.001]
None 748 (21.5) 312 (19.0) 444 (23.6)
Primary 1680 (47.6) 741 (45.1) 937 (49.8)
Secondary or higher 1091 (30.9) 590 (35.9) 500 (26.6)
Roof type [x2 = 5.30, p = 0.071]
Grass 2180 (61.0) 1007 (60.3) 1171 (61.7)
Iron sheet 1302 (35.9) 629 (37.7) 671 (35.3)
Asbestos 91 (2.5) 33 (2.0) 57 (3.0)
Dengue virus Infection [x2 = 0.01, p = 1.000]
Yes 149 (4.1) 69 (4.1) 78 (4.1)
No 3475 (95.9) 1599 (95.9) 1824 (95.9)
Occupation [x2 = 245.60, p < 0.001]
House wife/husband 307 (8.7) 18 (1.1) 289 (15.4)
Farming 1233 (35.1) 573 (35.1) 659 (35.1)
Other 387 (11.0) 232 (14.2) 155 (8.3)
Student 1590 (45.2) 811 (49.6) 775 (41.3)The bivariate analysis (Table 2) reveals that there was
an association between age, education, use of mosquito
net, roof type and visit to Angola on one hand and
dengue virus infection on the other. In multivariate analysis
(Table 2), age, roof type, use of ITNs and visitation to
Angola remained significantly associated with dengue virus
infection. The association of age with dengue infection
shows that participants below 5 years of age were 63%
(AOR= 0.37; 95% CI [0.16, 0.86]) less likely to be infected
with dengue compared to those aged 45 years or older. A
significant association was also observed between grass
thatched roofing and dengue infection (AOR = 2.28; 95%
CI [1.15,4.53]). The respondents who used ITNs were 21%
(AOR = 1.21; 95% CI [1.01,1.44]) more likely to be
infected with dengue infection compared to those
who did not use ITNs. Persons who visited Angola
were 73% (AOR = 1.73; 95% CI [1.27, 2.35]) more
likely to be infected with dengue virus compared to
those who did not visit Angola.
Discussion
This is the first study that provides evidence on circula-
tion of dengue infection and its correlates in Zambia.
Furthermore there is no reported case of clinical dengue
infection in Zambia. The results in this study indicate a
sero-prevalence of dengue specific IgG antibodies of 4.1%.
Multivariate analyses revealed age, roof type, use of
ITNs and visit to Angola as factors associated with
dengue infection. The population under five years of age
were less likely to have dengue infection, while those
who travelled to Angola were more likely to have dengue
infection. The relationship between age and risk of
dengue has not been consistent. According to Egger and
Coleman, the risk for age in relation to classic dengue
fever had never been quantified. Using data from clinical
patients, Egger and Coleman showed that the risk of
classical dengue after primary dengue increased with age
[26]. Other studies have revealed that classic dengue is
primarily common among older children and adults
[6,24]. In a letter to the editor, Cavalcanti et al. indicated
that epidemiologic characteristics of Dengue differ by
age [27]. The age related association in our study is
consistent with other studies that show dengue infection
being more common among older children and adults [27].
The association of roof type with dengue infection are
inconsistent in studies of seroprevalence of Dengue fever
and other flaviviruses. A study on rural Cameroonian
populations indicates the odds of dengue seropositivity
were significantly lower among individuals with grass or
thatched roofs versus those individuals with corrugated
tin roofs with unfinished ceilings [28]. However our
findings are consistent with a Kenyan study that indicate
corrugated metal and thatch roofing were associated
with increased odds of antibodies against seropositivity
Figure 1 Spatial distribution of Dengue specific IgG positive.
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be an important risk factor in exposure to infected
mosquitoes.
Our findings in the study reveal that up to 21% of the
respondents using ITNs were more likely to be infected
with Dengue fever. This is contrast to the findings in
Haiti which suggest that ITNs may have protected their
study subjects against dengue transmission [30]. We
may assume that factors that could have contributed to
the risk of Dengue infection in the Zambian population
under study include the activities of the vector, Aedes
aegypti, that of the human host and a possible bias in
answering the questionnaire on use of ITNs. Aedes aegypti
commonly bites during the day [31] and therefore the
use of ITNs would not be expected to provide a barrier
between the humans and this Dengue fever transmitting
vector. Considering the outdoor activities participated
in during the day including farming, fishing, and
socialising, the population may be at risk of being bitten
by the vector.
Although there is evidence of dengue circulating and
being endemic in Africa [12-14,18] including Zambia’s
neighbours, evidence of dengue virus in Zambia has
neither been confirmed nor documented except for aconfirmed case of a European traveller/expatriate who
was in Zambia between 1987 and 1993 [15]. The disease
in Africa, including Zambia is probably not or under
reported for various reasons including low awareness of
disease among health providers, lack of relevant diagnostic
systems and poor surveillance [15].
There is evidence of ongoing dengue outbreaks in
Africa in Angola, Democratic Republic of Congo,
Mozambique, Tanzania and Seychelles. Two of these
countries, Democratic Republic of Congo and Tanzania
are neighbouring countries to Zambia. A major drive seen
to be contributing to the spread of dengue virus to urban
centres around the world is modern transportation
and travel to endemic areas [32-35]. The international
boundaries within Africa tend to divide villages, with
inhabitants of the same family living on either side of
the border. This and other factors including small scale
trade, and search for medical facilities necessitates
frequent travels across the border.
Considering the proximity of North-Western and
Western provinces to Angola and a significant association
of dengue infection with travel to Angola, we may assume
that the outbreak in Angola may have affected the
Zambian population in the two study sites.
Table 2 Factors associated with Dengue virus infection in
logistic regression analysis for North-Western and
Western provinces
Factor OR (95% CI) AOR (95% CI)
Age (years)
<5 0.41 (0.20, 0.88) 0.37 (0.16, 0.86)
5-14 0.79 (0.53, 1.17) 0.92 (0.62, 1.38)
15-24 0.92 (0.62, 1.36) 0.98 (0.65, 1.47)
25-34 1.35 (0.93, 1.97) 1.38 (0.94, 2.03)
35-44 0.98 (0.62, 1.56) 0.94 (0.59, 1.50)
45+ 1 1
Sex
Male 1.01 (0.85, 1.19) -
Female 1
Education
None 0.85 (0.63, 1.14) -
Primary 1.29 (1.03, 1.61) -
Secondary or higher 1
Use of an Insecticide Treated Net
Yes 1.20 (1.01, 1.43) 1.21 (1.01, 1.44)
No 1 1
Insecticide Residual Spraying
Yes 0,99 (0.80, 1.21) -
No 1
Visited Congo DRC
Yes 0.49 (0.18, 1.30) -
No 1
Visited Angola
Yes 2.00 (1.49, 2.68) 1.73 (1.27, 2.35)
No 1 1
Roof type
Grass 2.33 (1.18, 4.60) 2.28 (1.15, 4.53)
Iron sheet 0.94 (0.46, 1.90) 0.98 (0.49, 1.99)
Asbestos 1 1
Occupation
House wife/husband 1.01 (0.65, 1.57) -
Farming 1.37 (1.05, 1.79)
Other 1.18 (0.80, 1.73)
Student 1
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tion neutralization tests (PRNTs) to increase the specifi-
city of ELISA testing and reduce potential cross reactivity
were not performed. However, the IgG capture-ELISA test
used is a suitable tool to detecting dengue IgG antibodies
in large epidemiologic surveys [36] although caution must
be taken knowing that cross-reactivity may occur with
other Flavivirus antibodies [37].Conclusion
This study provides the first evidence of dengue virus
circulation in North-Western and Western provinces of
Zambia. It is important that surveillance activities for
dengue and diagnostic systems are expanded and strength-
ened, nationwide in order to capture information related to
dengue virus and other flaviviruses. This may reveal the fact
that dengue should be considered as a disease of public
health importance.
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